{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T10:14:22Z","timestamp":1742638462576},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T00:00:00Z","timestamp":1466985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Key Project of Tianjin","award":["14ZCZDSY00013"],"award-info":[{"award-number":["14ZCZDSY00013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12010-016-2166-9","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T09:53:50Z","timestamp":1467021230000},"page":"1276-1285","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Toxicology Assessment of a Dual-Function Peptide 5rolGLP-HV in Mice"],"prefix":"10.1007","volume":"180","author":[{"given":"Zaizhong","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huikun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingzhe","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangzhen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,27]]},"reference":[{"key":"2166_CR1","doi-asserted-by":"crossref","unstructured":"Ni, Z., Zhang, Y., Wang, H., Wei, Y., Ma, B., Hao, J. et al (2016). Construction of a fusion peptide 5rolGLP-HV and analysis of its therapeutic effect on type 2 diabetes mellitus and thrombosis in mice. Applied Biochemistry and Biotechnology.","DOI":"10.1007\/s12010-016-1979-x"},{"issue":"3","key":"2166_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.taap.2012.11.015","volume":"266","author":"Y Yu","year":"2013","unstructured":"Yu, Y., Wang, X., Liu, C., Yao, D., Hu, M., Li, J., et al. (2013). Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats. Toxicology and Applied Pharmacology, 266(3), 375\u2013384.","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"4","key":"2166_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jcp.2006.043232","volume":"61","author":"LR Ranganath","year":"2008","unstructured":"Ranganath, L. R. (2008). Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. Journal of Clinical Pathology, 61(4), 401\u2013409.","journal-title":"Journal of Clinical Pathology"},{"issue":"3","key":"2166_CR4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","volume":"113","author":"ME Doyle","year":"2007","unstructured":"Doyle, M. E., & Egan, J. M. (2007). Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacology & Therapeutics, 113(3), 546\u2013593.","journal-title":"Pharmacology & Therapeutics"},{"issue":"6","key":"2166_CR5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","volume":"17","author":"JE Campbell","year":"2013","unstructured":"Campbell, J. E., & Drucker, D. J. (2013). Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metabolism, 17(6), 819\u2013837.","journal-title":"Cell Metabolism"},{"issue":"5","key":"2166_CR6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clinthera.2013.03.011","volume":"35","author":"RR Henry","year":"2013","unstructured":"Henry, R. R., Logan, D., Alessi, T., & Baron, M. A. (2013). A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes. Clinical Therapeutics, 35(5), 634\u2013645 e631.","journal-title":"Clinical Therapeutics"},{"issue":"10","key":"2166_CR7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s10529-007-9427-1","volume":"29","author":"J Hou","year":"2007","unstructured":"Hou, J., Yan, R., Ding, D., Yang, L., Wang, C., Wu, Z., et al. (2007). Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21(DE3) in streptozotocin-induced diabetic rats. Biotechnology Letters, 29(10), 1439\u20131446.","journal-title":"Biotechnology Letters"},{"issue":"6","key":"2166_CR8","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1271\/bbb.60694","volume":"71","author":"J Hou","year":"2007","unstructured":"Hou, J., Yan, R., Yang, L., Wu, Z., Wang, C., Ding, D., et al. (2007). High-level expression of fusion protein containing 10 tandem repeated GLP-1 analogs in yeast Pichia Pastoris and its biological activity in a diabetic rat model. Bioscience, Biotechnology, and Biochemistry, 71(6), 1462\u20131469.","journal-title":"Bioscience, Biotechnology, and Biochemistry"},{"issue":"6","key":"2166_CR9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/138920101606150407114815","volume":"16","author":"P Tu","year":"2015","unstructured":"Tu, P., Ma, Z., Wang, H., Ma, B., Li, X., Duan, H., et al. (2015). Expression of CTB-10xrolGLP-1 in E. coli and its therapeutic effect on type 2 diabetes. Current Pharmaceutical Biotechnology, 16(6), 564\u2013572.","journal-title":"Current Pharmaceutical Biotechnology"},{"issue":"4","key":"2166_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0033-1363281","volume":"122","author":"B Ma","year":"2014","unstructured":"Ma, B., Hu, X., Zhao, X., Zhang, Y., Li, C., Ma, Z., et al. (2014). Pharmacokinetics, pharmacodynamics, and cytotoxicity of recombinant orally-administrated long-lasting GLP-1 and its therapeutic effect on db\/db mice. Experimental and Clinical Endocrinology and Diabetes, 122(4), 215\u2013221.","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"issue":"24","key":"2166_CR11","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1007\/s11434-009-0699-9","volume":"54","author":"L Zhao","year":"2009","unstructured":"Zhao, L., Liao, F., Wang, C. Y., Chen, M., Wei, A. M., Du, S. L., et al. (2009). Generation of transgenic cucumbers with expression of a ten-tandem repeat long-acting GLP-1 analogue and their biological function on diabetic rats. Chinese Science Bulletin, 54(24), 4658\u20134663.","journal-title":"Chinese Science Bulletin"},{"issue":"2","key":"2166_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cbi.2008.02.012","volume":"173","author":"Y Ou","year":"2008","unstructured":"Ou, Y., Liao, G. Y., & Wu, W. T. (2008). Potential use of hirudin in diabetic cataract: a study of galactose mediated human lens epithelial cells injury. Chemico-Biological Interactions, 173(2), 141\u2013147.","journal-title":"Chemico-Biological Interactions"},{"issue":"4","key":"2166_CR13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.peptides.2005.08.015","volume":"27","author":"X Cen","year":"2006","unstructured":"Cen, X., Ni, J., Tan, T., Liu, X., Li, C., Chen, J., et al. (2006). Investigation on recombinant hirudin via oral route. Peptides, 27(4), 836\u2013840.","journal-title":"Peptides"},{"issue":"1","key":"2166_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.beha.2004.02.002","volume":"17","author":"TE Warkentin","year":"2004","unstructured":"Warkentin, T. E. (2004). Bivalent direct thrombin inhibitors: hirudin and bivalirudin. Best Practice & Research. Clinical Haematology, 17(1), 105\u2013125.","journal-title":"Best Practice & Research. Clinical Haematology"},{"key":"2166_CR15","doi-asserted-by":"crossref","unstructured":"Wang, X. D., Hu, J. J., Pan, D. T., Teng, H., & Xiu, Z. L. (2014). PEGylation kinetics of recombinant hirudin and its application for the production of PEGylated HV2 species. Biochemical Engineering Journal, 8538\u20138548.","DOI":"10.1016\/j.bej.2014.01.012"},{"issue":"1\u20132","key":"2166_CR16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-9673(02)01401-2","volume":"979","author":"R Donges","year":"2002","unstructured":"Donges, R., & Brazel, D. (2002). Determination of recombinant hirudin structural deviants by capillary zone electrophoresis augmented with buffer additives. Journal of Chromatography. A, 979(1\u20132), 217\u2013226.","journal-title":"Journal of Chromatography. A"},{"issue":"1","key":"2166_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pep.2006.06.004","volume":"50","author":"R Kochanowski","year":"2006","unstructured":"Kochanowski, R., Kotlowski, R., & Szweda, P. (2006). Novel method of expression and purification of hirudin based on pBAD TOPO, pTYB12 vectors and gene synthesis. Protein Expression and Purification, 50(1), 25\u201330.","journal-title":"Protein Expression and Purification"},{"issue":"3","key":"2166_CR18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.peptides.2004.10.003","volume":"26","author":"Y Liu","year":"2005","unstructured":"Liu, Y., Lu, W. L., Zhang, X., Wang, X. Q., Zhang, H., & Zhang, Q. (2005). Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes. Peptides, 26(3), 423\u2013430.","journal-title":"Peptides"},{"issue":"2","key":"2166_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.taap.2014.01.021","volume":"276","author":"R Rouse","year":"2014","unstructured":"Rouse, R., Xu, L., Stewart, S., & Zhang, J. (2014). High fat diet and GLP-1 drugs induce pancreatic injury in mice. Toxicology and Applied Pharmacology, 276(2), 104\u2013114.","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"2166_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.taap.2012.08.008","volume":"264","author":"LW Zhang","year":"2012","unstructured":"Zhang, L. W., Tobin, G. A. M., & Rouse, R. L. (2012). Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line. Toxicology and Applied Pharmacology, 264(2), 274\u2013283.","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"2166_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00125-009-1515-4","volume":"53","author":"JS Nachnani","year":"2010","unstructured":"Nachnani, J. S., Bulchandani, D. G., Nookala, A., Herndon, B., Molteni, A., Pandya, P., et al. (2010). Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia, 53(1), 153\u2013159.","journal-title":"Diabetologia"},{"issue":"7","key":"2166_CR22","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db12-1686","volume":"62","author":"AE Butler","year":"2013","unstructured":"Butler, A. E., Campbell-Thompson, M., Gurlo, T., Dawson, D. W., Atkinson, M., & Butler, P. C. (2013). Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes, 62(7), 2595\u20132604.","journal-title":"Diabetes"},{"issue":"4","key":"2166_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1185\/03007990902820519","volume":"25","author":"DD Dore","year":"2009","unstructured":"Dore, D. D., Seeger, J. D., & Chan, K. A. (2009). Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Current Medical Research and Opinion, 25(4), 1019\u20131027.","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"2166_CR24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2337\/dc09-1499","volume":"33","author":"DJ Drucker","year":"2010","unstructured":"Drucker, D. J., Sherman, S. I., Gorelick, F. S., Bergenstal, R. M., Sherwin, R. S., & Buse, J. B. (2010). Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care, 33(2), 428\u2013433.","journal-title":"Diabetes Care"},{"issue":"7","key":"2166_CR25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2337\/db09-0058","volume":"58","author":"AV Matveyenko","year":"2009","unstructured":"Matveyenko, A. V., Dry, S., Cox, H. I., Moshtaghian, A., Gurlo, T., Galasso, R., et al. (2009). Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes interactions with metformin. Diabetes, 58(7), 1604\u20131615.","journal-title":"Diabetes"},{"issue":"1","key":"2166_CR26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4158\/EP09104.CRR","volume":"16","author":"WA Ayoub","year":"2010","unstructured":"Ayoub, W. A., Kumar, A. A., Naguib, H. S., & Taylor, H. C. (2010). Exenatide-induced acute pancreatitis. Endocrine Practice, 16(1), 80\u201383.","journal-title":"Endocrine Practice"},{"issue":"2","key":"2166_CR27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/diacare.29.02.06.dc05-2043","volume":"29","author":"PS Denker","year":"2006","unstructured":"Denker, P. S., & Dimarco, P. E. (2006). Exenatide (exendin-4)-induced pancreatitis: a case report. Diabetes Care, 29(2), 471.","journal-title":"Diabetes Care"},{"issue":"5","key":"2166_CR28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1345\/aph.1M676","volume":"44","author":"SL Anderson","year":"2010","unstructured":"Anderson, S. L., & Trujillo, J. M. (2010). Association of Pancreatitis with glucagon-like peptide-I agonist use. Annals of Pharmacotherapy, 44(5), 904\u2013909.","journal-title":"Annals of Pharmacotherapy"},{"issue":"1","key":"2166_CR29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","volume":"141","author":"M Elashoff","year":"2011","unstructured":"Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., & Butler, P. C. (2011). Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology, 141(1), 150\u2013156.","journal-title":"Gastroenterology"},{"issue":"3","key":"2166_CR30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pds.3542","volume":"23","author":"XC Li","year":"2014","unstructured":"Li, X. C., Zhang, Z. Y., & Duke, J. (2014). Glucagon-like peptide 1-based therapies and risk of pancreatitis: a self-controlled case series analysis. Pharmacoepidemiology Drug Safety, 23(3), 234\u2013239.","journal-title":"Pharmacoepidemiology Drug Safety"},{"issue":"3","key":"2166_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1345\/aph.1A204","volume":"36","author":"WE Dager","year":"2002","unstructured":"Dager, W. E., & White, R. H. (2002). Treatment of heparin-induced thrombocytopenia. The Annals of Pharmacotherapy, 36(3), 489\u2013503.","journal-title":"The Annals of Pharmacotherapy"},{"issue":"9","key":"2166_CR32","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.fct.2007.03.013","volume":"45","author":"K Babicek","year":"2007","unstructured":"Babicek, K., Cechova, I., Simon, R. R., Harwood, M., & Cox, D. J. (2007). Toxicological assessment of a particulate yeast (1,3\/1,6)-beta-D-glucan in rats. Food and Chemical Toxicology, 45(9), 1719\u20131730.","journal-title":"Food and Chemical Toxicology"},{"issue":"8","key":"2166_CR33","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.fct.2008.04.026","volume":"46","author":"S Yee","year":"2008","unstructured":"Yee, S., Burdock, G. A., Kurata, Y., Enomoto, Y., Narumi, K., Hamada, S., et al. (2008). Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae. Food and Chemical Toxicology, 46(8), 2713\u20132720.","journal-title":"Food and Chemical Toxicology"},{"key":"2166_CR34","doi-asserted-by":"crossref","unstructured":"Morsy, M. A., Heeba, G. H., & Mahmoud, M. E. (2015). Ameliorative effect of eprosartan on high-fat diet\/streptozotocin-induced early diabetic nephropathy in rats. European Journal of Pharmacology, 75090\u201375097.","DOI":"10.1016\/j.ejphar.2015.01.027"},{"key":"2166_CR35","doi-asserted-by":"crossref","unstructured":"Zhang, J., Gao, X., Pan, Y., Xu, N., & Jia, L. (2016). Toxicology and immunology of Ganoderma lucidum polysaccharides in Kunming mice and Wistar rats. International Journal of Biological Macromolecules, 85302\u201385310.","DOI":"10.1016\/j.ijbiomac.2015.12.090"},{"key":"2166_CR36","doi-asserted-by":"crossref","unstructured":"Huang, Q., Ihsan, A., Guo, P., Luo, X., Cheng, G., Hao, H., et al. (2016). Evaluation of the safety of primary metabolites of cyadox: acute and sub-chronic toxicology studies and genotoxicity assessment. Regulatory Toxicology and Pharmacology, 74123\u201374136.","DOI":"10.1016\/j.yrtph.2015.11.011"},{"issue":"18","key":"2166_CR37","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.lfs.2005.12.006","volume":"78","author":"NT Zaveri","year":"2006","unstructured":"Zaveri, N. T. (2006). Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sciences, 78(18), 2073\u20132080.","journal-title":"Life Sciences"},{"issue":"6","key":"2166_CR38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/003655201750163213","volume":"36","author":"R Segersvard","year":"2001","unstructured":"Segersvard, R., Sylvan, M., Herrington, M., Larsson, J., & Permert, J. (2001). Obesity increases the severity of acute experimental pancreatitis in the rat. Scandinavian Journal of Gastroenterology, 36(6), 658\u2013663.","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"3","key":"2166_CR39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5009\/gnl.2011.5.3.335","volume":"5","author":"KY Shin","year":"2011","unstructured":"Shin, K. Y., Lee, W. S., Chung, D. W., Heo, J., Jung, M. K., Tak, W. Y., et al. (2011). Influence of obesity on the severity and clinical outcome of acute pancreatitis. Gut Liver, 5(3), 335\u2013339.","journal-title":"Gut Liver"},{"issue":"10","key":"2166_CR40","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.fct.2007.04.013","volume":"45","author":"AM Flammang","year":"2007","unstructured":"Flammang, A. M., Erexson, G. L., Mirwald, J. M., & Henwood, S. M. (2007). Toxicological and cytogenetic assessment of a Salacia oblonga extract in a rat subchronic study. Food and Chemical Toxicology, 45(10), 1954\u20131962.","journal-title":"Food and Chemical Toxicology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-016-2166-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-016-2166-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-016-2166-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-016-2166-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T22:51:49Z","timestamp":1718664709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-016-2166-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,27]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1007\/s12010-016-2166-9","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,27]]}}}